Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.

@article{Douketis2000ClinicalRF,
  title={Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.},
  author={James Demetrios Douketis and Gregory A. Foster and Mark Andrew Crowther and Martin H. Prins and Jeffrey S. Ginsberg},
  journal={Archives of internal medicine},
  year={2000},
  volume={160 22},
  pages={3431-6}
}
BACKGROUND In patients with venous thromboembolism (VTE), identifying clinical risk factors for recurrence during the initial 3 months of anticoagulant therapy and knowledge of the time course of recurrence may help clinicians decide about the frequency of clinical surveillance and the appropriateness of outpatient treatment. METHODS Analysis of a randomized controlled trial database involving 1021 patients with VTE (750 with deep vein thrombosis [DVT] and 271 with pulmonary embolism [PE… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 77 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Risk factors for bleeding during treatmentof acutevenous thromboembolism

  • JPJ Wester, HW de Valk, HK Nieuwenhuis
  • ThrombHaemost
  • 1996
Highly Influential
12 Excerpts

Similar Papers

Loading similar papers…